The bill H.581, introduced by Representative Burrows, aims to modify the reporting requirements for controlled substances prescribed for reproductive and gender-affirming health care services within the Vermont Prescription Monitoring System (VPMS). Specifically, it proposes that such medications will not need to be reported unless the Commissioner of Health determines that reporting is necessary for public health protection. Additionally, any information regarding these medications in the VPMS will be excluded from sharing with other states' prescription monitoring systems.

To implement these changes, the bill amends existing legal language in 18 V.S.A. § 4283 and § 4288. It adds a provision that exempts medications prescribed for reproductive and gender-affirming health care from reporting requirements, unless deemed necessary by the Commissioner. Furthermore, it stipulates that reciprocal agreements with other states must exclude any information related to these specific medications and their prescribers, dispensers, and recipients from being disclosed. The act is set to take effect on July 1, 2026.

Statutes affected:
As Introduced: 18-4283, 18-4288